← Back to headlines
Fulcrum Therapeutics Shares Climb After Outperforming Q1 Earnings Expectations
Fulcrum Therapeutics' shares have risen following the announcement that its first-quarter earnings exceeded market expectations.
27 Apr, 15:08 — 27 Apr, 15:08
Sources
Showing 1 of 1 sources
